Renal insufficiency, hyperparathyroidism, neuroendocrine neoplasms (NENs), and non‐neuroendocrine carcinomas (lung, colon, breast, and prostate carcinomas) can all raise serum calcitonin levels, as can some medicines.2 Here, CALCA is linked to hyperparathyroidism.